Steep Decline in Chlamydia, Syphilis Rates ‘Seals the Case’ for DoxyPEP
DENVER — Chlamydia and early syphilis cases among at-risk individuals were halved after the introduction of doxycycline post-exposure prophylaxis (doxyPEP), real-world data from San Francisco showed. Over a 13-month period following the rollout of doxyPEP to high-risk men who have sex with men (MSM) and transgender women, monthly chlamydia cases decreased by 50% (95% CI […]